The results reported by Bovijn et al. [37] may be subject to residual confounding, as neither arterial hypertension nor diabetes mellitus was observed in sclerostin gene knockout animals or preclinical and clinical studies with anti-sclerostin antibodies. The gene discussed is SOST; the disease is diabetes mellitus.